CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 48 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2019. The put-call ratio across all filers is 0.43 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $224,000 | -37.6% | 8,322 | -65.6% | 0.01% | 0.0% |
| Q3 2020 | $359,000 | +42.5% | 24,180 | +24.6% | 0.01% | +71.4% |
| Q2 2020 | $252,000 | +1160.0% | 19,401 | +61.3% | 0.01% | +600.0% |
| Q1 2020 | $20,000 | -71.8% | 12,027 | -62.4% | 0.00% | 0.0% |
| Q4 2019 | $71,000 | -1.4% | 32,027 | -4.9% | 0.00% | 0.0% |
| Q3 2019 | $72,000 | – | 33,661 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 3,200,000 | $88,064,000 | 14.40% |
| Octagon Capital Advisors LP | 759,898 | $20,912,393 | 3.21% |
| TSP Capital Management Group, LLC | 251,695 | $6,926,645 | 2.67% |
| 5AM Venture Management, LLC | 310,270 | $8,538,630 | 2.46% |
| COMMODORE CAPITAL LP | 706,665 | $19,447,421 | 2.27% |
| ACUTA CAPITAL PARTNERS, LLC | 122,341 | $3,366,824 | 2.26% |
| Redmile Group, LLC | 1,635,938 | $45,021,014 | 2.14% |
| RTW INVESTMENTS, LP | 3,463,201 | $95,307,292 | 2.01% |
| Eversept Partners, LP | 588,143 | $16,185,695 | 1.37% |
| Affinity Asset Advisors, LLC | 150,000 | $4,128,000 | 1.16% |